Background The patient's perspective of their facial scar after skin cancer surgery influences perception of care and quality of life (QoL). Appearance satisfaction after surgery is also an important but often overlooked treatment outcome. Objectives To report the psychometric validation of the FACE-Q Skin Cancer Module consisting of five scales, measuring appearance satisfaction (Satisfaction with Facial Appearance, Appraisal of Scars), QoL (Cancer Worry, Appearance-related Psychosocial Distress) and the patient experience (Satisfaction with Information: Appearance). Methods Participants underwent Mohs surgery for facial basal or squamous cell carcinoma or excision of early facial melanoma. Cohort 1 received a set of scales before and after surgery. Cohort 2 received the scales on two occasions in the postoperative period for test-retest reliability. Rasch measurement theory was used to select (item-reduce) the most clinically meaningful items for the scales. Reliability, validity, floor and ceiling effects and responsiveness were also analysed. Results Of 334 patients, 209 (response rate 62Á6%) were included. Rasch analysis reduced the total scale items from 77 to 41. All items had ordered thresholds and good psychometric fit. Reliability was high (Person separation index and Cronbach's a ≥ 0Á90) and scales measuring similar constructs were correlated. High floor and ceiling effects were seen for the scales. The Cancer Worry scale demonstrated responsiveness (P = 0Á004). Conclusions The FACE-Q Skin Cancer Module meet the requirements of the Rasch model providing linearized measurement. Discriminating between patients with minimal appearance or worry impairment may be a limitation. The scales can be used for larger validation studies, clinical practice and research.
What are the clinical implications of the work?
• The FACE-Q Skin Cancer Module is recommended for clinical care to improve individual patient outcomes and to inform research studies.
As the incidence of nonmelanoma skin cancer (NMSC) and melanoma has risen globally over the last few decades, 1,2 surgical management of facial skin malignancies has also increased. 3 Studies have shown that skin tumours located on the face and facial scarring are associated with significant psychological morbidity. 4, 5 As physical appearance directly influences emotions and social interactions, scarring from facial surgery can impact an individual's self-perception. The patient's perspective of their aesthetic outcome is becoming increasingly important. However, as appearance is subjective, patient-reported outcome (PRO) instruments are questionnaires designed to quantify the patient's perspective of their disease and/or treatment. The patient's assessment of their aesthetic outcome after surgery can differ from the surgeon's perspective. 6, 7 Furthermore, this perception markedly influences the patient's satisfaction with the overall care provided. 8 Patients may be dissatisfied if their scar size is greater than anticipated; others will struggle to adapt to appearance changes, leading to anxiety, social isolation and a decreased quality of life (QoL). 9, 10 Although patients express concerns related to scar appearance, it is minimally addressed by validated measures. 11 In a systematic review performed by the authors of PRO instruments used in NMSC, only the Skin Cancer Index addressed appearance, with limited questions about attractiveness and scar size/noticeability. 12 Attributes related to overall appearance and scarring may contribute to dissatisfaction and psychosocial distress yet are not addressed by existing PRO instruments, suggesting that a more comprehensive instrument is needed. The vast majority of existing PRO instruments were developed and validated with the traditional classic test theory approach; however, newer or modern psychometric approaches (e.g. Rasch Measurement Theory, RMT) improve the clinical interpretation of the scale scores. 13 In this approach, the qualitative phase is crucial as it provides data that can be used to create the content for a set of independently functioning scales, each of which functions like a 'ruler' whereby the items map out a clinical hierarchy to reflect less of the concept (e.g. cancer worry) at one end of the scale to more of the concept at the other end. The fieldtest data is then analysed to see if the scale's clinical hierarchy worked as hypothesized. When data collected for a scale meet the requirements of the Rasch model, the scale can be said to provide linearized measurement. The FACE-Q 14-19 is a multimodule PRO instrument developed for the aesthetic patient undergoing elective surgical and nonsurgical procedures. The FACE-Q Skin Cancer Module was developed for patients undergoing surgical procedures for facial skin cancers, as additional concerns were identified by our group such as cancer worry and appearance (i.e. scarring), similar to previous research in this area. 11, 20, 21 The module consists of five scales that address constructs identified to be important to patients with facial skin cancer. 20 In this study, the FACE-Q Skin Cancer Module scales are psychometrically analysed and validated with a modern psychometric approach for clinical use in the population with skin cancer.
Methods
Ethics review board approval was obtained from the Institutional Review Board at Memorial Sloan Kettering Cancer Center (MSKCC). The FACE-Q Skin Cancer Module was developed according to the U.S. Food and Drug Administration guidance to industry and other recommended guidelines for the development of a PRO instrument. [22] [23] [24] [25] To develop the conceptual framework and scales, a pool of items was generated from three sources: a systematic review of the literature, 12 qualitative interviews and expert opinion. In-depth qualitative interviews were conducted with 15 participants with NMSC and early-stage melanoma to generate the themes most important to the patients. The themes included appearance-related concerns, psychological and social function, adverse problems and the experience of care. 20 Participants were also shown the FACE-Q Satisfaction with Facial Appearance and Psychological Distress scales 14, 18 to identify items that might be relevant to patients with skin cancer. Examples of response options for possible inclusion were also reviewed for feedback. The Face-Q Skin Cancer Module consists of two scales related to appearance, two QoL scales and one patient experience scale (Table 1 ). All the scales were developed with four response options in keeping with the best practice for scale development. 26 The scales are available in Appendix S1 (see Supporting Information). The scales were pilot-tested with five participants to clarify ambiguities, confirm acceptability and completion time. To determine the final number of items in each of the scales and checklists, a field-test study was performed.
Data collection for field-testing (phase II)
We Appearance) with instructions to complete one set upon receipt of the package and the second 2 weeks later. The participants were asked to answer the questions in reference to their most recent skin cancer treatment. To increase participation, a gift card incentive was included. The participants also received a reminder letter and telephone call.
The scales are scored separately. For each scale, if missing data comprised less than 50% of the scale's items, the responses were summed. Using a conversion table specific to each scale, the Rasch logit scores were transformed into 0 to 100. Higher scores for the two Appearance scales and the Information scale indicated a better outcome, whereas higher scores for Cancer Worry and Psychosocial Distress scales indicated worse outcomes.
Statistical analysis
RMT analysis 27, 28 was used to select the items for the final versions of the scales with RUMM2030 statistical software. 29 The analysis uses a number of statistical and graphic tests to examine each item in a scale [30] [31] [32] and considers the results together when making decisions about the overall scale quality. For the five scales we performed the following: Cronbach's a was computed for each scale, which provides a measure of how closely related a set of items are as a group (internal consistency). 33 For test-retest reliability, interclass correlation (ICC) was computed. 34 Floor and ceiling effects for each scale were also calculated. For responsiveness, we computed group-level change for the two scales (Cancer Worry and Appearance-related Psychosocial Distress) completed by a subgroup before and after surgery. Cancer Worry was anticipated to decrease after surgery, whereas Appearance-related Distress was expected to remain the same or increase after surgery. We compared preoperative and postoperative Rasch transformed scores using 
35-38

Construct validity
Pearson correlations were performed to examine associations among scores and two-tailed independent sample t-tests to assess for differences among means to test the hypotheses:
1 Scales measuring similar constructs (e.g. appearance) would correlate more with each other. 2 Higher Cancer Worry scores (more worry) would correlate with higher Appearance-related Psychosocial Distress (more distress). Degree of Cancer Worry may also correlate with Appearance scores with more worry being associated with lower facial satisfaction and more scar bother.
Results
Response rate and sample characteristics
A total of 334 participants were approached, of whom 89 participants were enrolled in cohort 1 and 120 participants in cohort 2 (already had surgery), for an overall response rate of 62Á6%. In cohort 1, the participants completed the postoperative scales at a median of 16 days after surgery. In cohort 2, 52 participants filled out the scales a second time for the testretest (43Á3%) at an average of 26 days (median 17 days, range 12-105 days). There was one outlier of 105 days and without this outlier, the maximum number of days was 62. Patient characteristics of the sample are summarized in Table 2 .
Rasch measurement theory analysis
The RMT analysis supported the reliability and validity of the five independent scales. The Satisfaction with Facial Appearance scale was reduced from 14 to nine items, Appraisal of Scars from 13 to eight items, Cancer Worry from 15 to 10 items, Appearance-related Psychosocial Distress from 15 to eight items, and Satisfaction with Information: Appearance from 20 to six items. All 41 items had ordered thresholds, which provide evidence that the response options for each scale worked as a continuum that increased for the construct being measured. Only one item was minimally outside the À2Á5 to +2Á5 range (Table S1 ; see Supporting Information). This item (Information scale: options scar) was retained, given that the other fit statistics were satisfied. The v 2 P-values for all 41 items were nonsignificant, also indicating good item fit. For dependency, the item residuals were above 0Á30 for four pairs of items; however, subtests performed revealed only a marginal effect on the scale reliability (0 to 0Á01 differences in PSI value). In Figure 1 , this histogram shows how well the participants are measured by the items of the Cancer Worry scale. The top histogram shows the frequency of person estimates (or measurements) and the bottom histogram shows the frequency of item thresholds (for each response option for each item). Less Cancer Worry is represented towards the left of the histograms, more to the right. For 88% of the sample there is good coverage of item thresholds, meaning there are items to verbalize the different levels of Cancer Worry for each of these participants. Conversely, 12% of the sample scored at the floor of the scale and, therefore, are not covered by the scale content. The five scales demonstrate high reliability. The PSI ranged from 0Á80 to 0Á91 (with extremes) and 0Á85 to 0Á90 (with no extremes), indicating good internal reliability (Table 3) . Cronbach's a values were 0Á93 and higher. The ICC value was 0Á93 and higher for the Appearance, Scar, Psychosocial Distress and Information scales and 0Á76 for Cancer Worry. The Appearance-related Psychosocial Distress scale shows a floor effect of 40% and for the Cancer Worry scale, 15%. The ceiling effects were > 30% for the two Appearance scales and the Satisfaction with Information scale.
The endorsement frequencies and missing values for the five scales are provided in Table S2 (see Supporting Information). The endorsement frequencies show the clinical hierarchy for each scale. For example, for the Satisfaction with Facial Appearance scale, the clinical hierarchy ranges from the item 'The shape of your face', which had 64% of participants indicate they were very satisfied, to 'How your face looks up close', which had 40% of participants indicate they were very satisfied. Between the two ends of the 'ruler', the remaining eight items mapped out the scales concept in terms of decreasing satisfaction with appearance of the face.
Responsiveness
Sixty-three participants completed the Cancer Worry and Appearance-related Psychosocial Distress scales before and after surgery. Cancer Worry scores changed from a mean of 40Á2 (SD 17Á6) before surgery to 32Á2 (SD 20Á8) after surgery (P = 0Á004, effect size 0Á46), which shows a significant improvement after surgery, and a moderate effect size. The Psychosocial Distress scale scores did not have a significant change before [mean score 18Á6 (SD 16Á1)] and after [19Á9 (SD 20Á3)] surgery (P = 0Á61, effect size À0Á1).
Construct validity
Pearson correlations between the Appearance [Facial Appearance and Scar (0Á55, P = 0Á01)] and QoL scales [Cancer Worry and Appearance-related Psychosocial Distress (0Á39, P = 0Á01)] correlated and were significant. Higher Cancer Worry scores correlated with more Appearance-related Psychosocial Distress (0Á39, P = 0Á01) and less satisfaction with Facial Appearance (À0Á18, P = 0Á01) and more Scar bother after surgery (À0Á27, P = 0Á01).
Discussion
Facial appearance defines an individual's identity, and directly influences emotions and social interactions. 39 Therefore, visible scarring can lead to anxiety, poor self-esteem and a decreased QoL. 40 While satisfaction with facial appearance after surgery is an important outcome, it is often overlooked in dermatological surgery. The FACE-Q Skin Cancer Module provides the dermatological and reconstructive surgery communities with a comprehensive set of meaningful and scientifically sound set of scales for the population with facial skin cancer.
The psychometric analyses provide evidence of reliability and validity of the five scales that comprise the FACE-Q Skin Cancer Module. The use of RMT methods has fundamental advantages. The RMT methods differ from traditional psychometric methods (based on classic test theory) because their focus is on the association between a person's measurement and the probability of responding to an item, rather than the association between a person's measurement and the observed scale total score. 30 Advantages of using RMT to develop PRO instruments include: (1) RMT provides measurements of people that are independent of the sampling distribution of the people in whom they are developed; (2) RMT improves the potential to diagnose item-level psychometric issues and (3) RMT allows for a more accurate picture of individual person measurements. 30 These qualities, together with the qualitative work performed to create the FACE-Q Skin Cancer Module, are what set it apart from other PRO instruments in the same clinical area. A recent Dutch questionnaire also utilized modern psychometrics (item-response theory); however, the appearance questions are limited to scar worry and attractiveness and not specific to scar attributes or overall facial appearance. 41 The two appearance scales ask about satisfaction with facial appearance and the degree of bother for different scar attributes, respectively. The majority of studies assessing QoL in the NMSC population use the Skindex-16, 12 a rigorously developed instrument that focuses on symptoms, emotions and physical/social limitations. 42 A PRO questionnaire specific to advanced BCC and BCC naevus syndrome showed that scarring was an important patient concern. 43 Studies have also demonstrated diminished QoL with scarring and the value of reconstruction of facial defects. 6, 39 Therefore, an instrument that measures facial appearance satisfaction and scar outcome is especially applicable to the skin cancer population. The Satisfaction with Information: Appearance scale inquires about scar and healing expectations. As patients' perception of their scars influences service perception, 8 this scale could be used to identify patient education gaps for an individual clinician and for larger quality-improvement efforts. The correlation between scales also showed more worry and appearancerelated distress were negatively correlated with appearance satisfaction, suggesting a potential relationship between these constructs for future studies. The scales could explore the driving factors for patient satisfaction; for example, addressing specific scar attributes may impact overall facial satisfaction and in turn, appearance-related distress. An advantage of using Rasch analysis as the statistical model is that the scores are interpreted for the individual person and not for group comparisons only. 44 The scale scores are interpreted at the individual level to offer tangible and unique clinical benefits for the clinician. We acknowledge that there could be some bias as the sample is from one institution and participants were not recruited consecutively. However, the responses were varied and a range of patients participated. The number of questionnaires filled out for each scale varied, reflecting the challenges of obtaining follow-up and mail surveys despite including a monetary incentive card. The presence of floor and ceiling effects in the current scales indicate an inability to differentiate between patients with low levels of impairment. It could be argued that this could be due to a limitation in the content validity of these scales. However, our previous research, 45 and extensive qualitative research developing the current scales, suggests that this is more likely a reflection of the clinical picture related to low morbidity. Thus, the floor effect for the Cancer Worry scale may reflect the perceived less serious nature of NMSC, for at least a proportion of patients. The observed greater ceiling effects (Facial Appearance, Scar Bother scales) and floor effect (Appearance-related Distress Scale) may reflect minimal impact of surgical scarring and successful healing experienced by many patients. Nevertheless, it is important to bear in mind that our scales are better targeted to those patients with greater impairments related to NMSC. The FACE-Q Skin Cancer Module is a promising new instrument that can be used by dermatological and plastic surgeons to evaluate their outcomes at the individual patient or larger practice level. The unique inclusion of Facial Appearance and Scar Appraisal and QoL allows for future studies comparing the long-term success of different surgical techniques from the patient's perspective. It could also aid in identifying patients at risk for poor outcomes and dissatisfaction and allow for rigorous studies in different age groups and anatomical locations to further validate the instrument. The FACE-Q Skin Cancer Module can be used for clinical practice, research or quality improvement and may complement existing clinician-based outcomes.
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